Bradley Herring - Jan 5, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Financial Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 04:36 PM
Previous filing
Dec 21, 2022
Next filing
Jan 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +40.7K +23.25% $0.00 216K Jan 5, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 13,563, 13,563 and 13,562 RSUs will vest on January 5, 2024, January 5, 2025 and January 5, 2026, respectively.